| EC Number | Inhibitors | Comment | Organism | Structure |
|---|---|---|---|---|
| 7.3.2.5 | additional information | not inhibitory: sulfate | Medicago truncatula |
| EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|---|
| 7.3.2.5 | membrane | - |
Medicago truncatula | 16020 | - |
| 7.3.2.5 | plasma membrane | - |
Medicago truncatula | 5886 | - |
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 7.3.2.5 | Medicago truncatula | - |
- |
- |
| EC Number | Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|---|
| 7.3.2.5 | root | endodermal cells in roots and nodules | Medicago truncatula | - |
| 7.3.2.5 | root nodule | endodermal cells in roots and nodules | Medicago truncatula | - |
| EC Number | Synonyms | Comment | Organism |
|---|---|---|---|
| 7.3.2.5 | Mot1.2 | - |
Medicago truncatula |
| EC Number | General Information | Comment | Organism |
|---|---|---|---|
| 7.3.2.5 | physiological function | a loss-of-function mutant shows reduced growth compared with wild-type plants when nitrogen fixation is required, but not when nitrogen is provided as nitrate. No effect on molybdenum-dependent nitrate reductase activity is observed, bute nitrogenase activity is severely affected. When grown in the presence of molybdate, yeast expressing MOT1.2 is able to accumulate Mo, with a Vmax of 155 pmol per million cells and h and a k1/2 of 488 nM | Medicago truncatula |